Samidorphan

萨米多芬

Report date: 2024/06/25 11:03:29
NME

Base Information

Drug NameSamidorphan
Drug Alias Namesamidorphan沙氨啡烷沙米啡烷samidorfanosamidorphanum +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsSchizophreniaBinge-Eating DisorderCocaine-Related Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute On Drug AbuseAlkermes Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaBinge-Eating DisorderCocaine-Related Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG